Anna Maria Di Giacomo

Anna Maria Di Giacomo is a prominent medical oncologist and a professor at the University of Siena, Italy. She is recognized for her significant contributions to melanoma research and immunotherapy, particularly in developing novel therapeutic strategies for metastatic melanoma. Her leadership in the NIBIT-M4 clinical study has provided crucial insights into the effectiveness of combined therapies for melanoma patients, advancing the understanding of how tumors respond to treatment.